Analyst
William Blair
Equibles does not estimate personal net worth.
Stephen Lichtman is recorded as Analyst at William Blair. Stephen Lichtman has spoken on 4 earnings calls across 3 companies, most recently for GLAUKOS Corp on July 29, 2026. Those appearances were for GLAUKOS Corp (GKOS), Alcon Inc (ALC) and Cooper Companies, Inc. (COO). The companies whose calls Stephen Lichtman spoke on are classified in the Healthcare sector.
“I'm wondering on your Epioxa customers how they're viewing the specialty pharmacy option versus buy-in bill. Are we seeing most go to specialty pharmacy initially?”
“Maybe start, Tim, with one quarter complete here, I'm wondering if you can provide any more color on the operating margin guidance range and whether you see a trending toward upper half or lower half for the year.”
“First, as it relates to the transition from Potrexa, are you still anticipating it, Potrexa, to fully sunset by the end of 3Q, or has there been any change in that plan?”
“Al, you mentioned reinvestment in myopia control, and it sounds like on the R&D side. Can you talk about the opportunities you see to build on the MySite platform from an innovation perspective?”
William Blair
Analyst
Transcript header (unverified)
GKOS
Medical Devices · Healthcare
ALC
Medical Instruments & Supplies · Healthcare
Medical Instruments & Supplies · Healthcare
